康泰生物
(300601)
| 流通市值：126.66亿 | | | 总市值：160.50亿 |
| 流通股本：8.81亿 | | | 总股本：11.17亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 190,632,300.7 | 323,144,611.76 | 876,163,610.61 | 1,195,582,446.07 |
| 应收票据及应收账款 | 2,878,860,051.21 | 2,802,996,728.95 | 2,715,699,475.44 | 2,787,608,436.63 |
| 其中：应收票据 | 49,545 | - | - | 0 |
| 应收账款 | 2,878,810,506.21 | 2,802,996,728.95 | 2,715,699,475.44 | 2,787,608,436.63 |
| 应收款项融资 | 0 | 0 | - | 190,406.6 |
| 预付款项 | 29,731,844.17 | 30,786,381.21 | 34,694,827.22 | 44,728,774.89 |
| 其他应收款合计 | 8,719,019.78 | 8,467,685.01 | 9,554,121.33 | 8,903,695.17 |
| 存货 | 868,334,750.87 | 894,840,348.36 | 896,004,327.54 | 772,853,528.55 |
| 其他流动资产 | 1,754,266,199.01 | 459,107,487.47 | 341,617,443.31 | 486,121,566.16 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,850,624,265.74 | 4,519,343,242.76 | 4,994,531,473.54 | 5,396,003,854.07 |
| 非流动资产: | | | | |
| 投资性房地产 | 489,733,719.06 | 494,915,534.04 | 420,348,019.01 | 423,773,120.66 |
| 固定资产 | 4,321,958,518.78 | 4,188,935,211.19 | 3,512,056,952.8 | 3,434,532,667.74 |
| 在建工程 | 1,311,496,175.49 | 1,478,247,083.05 | 2,218,041,532.6 | 2,281,452,384.28 |
| 无形资产 | 445,751,601.51 | 452,969,916.39 | 426,147,929.55 | 433,454,510.63 |
| 开发支出 | 81,086,019.24 | 51,878,743.89 | 76,241,601.56 | 70,783,976.01 |
| 长期待摊费用 | 75,555,755.03 | 84,179,616.53 | 92,299,192.51 | 101,681,117.15 |
| 递延所得税资产 | 643,572,146.18 | 657,140,703.73 | 623,497,037.46 | 630,317,234.27 |
| 其他非流动资产 | 1,295,761,513.46 | 2,517,845,804.62 | 2,657,558,847.82 | 2,313,359,670.46 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 8,664,915,448.75 | 9,926,112,613.44 | 10,026,191,113.31 | 9,689,354,681.2 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 14,515,539,714.49 | 14,445,455,856.2 | 15,020,722,586.85 | 15,085,358,535.27 |
| 流动负债: | | | | |
| 短期借款 | 155,678,905.79 | 158,600,438.82 | 206,956,615.9 | 60,043,333.33 |
| 应付票据及应付账款 | 789,032,555.1 | 794,781,234.34 | 779,481,780.78 | 882,481,513.73 |
| 其中：应付票据 | 162,189,348.62 | 98,349,733.25 | 95,243,758 | 91,304,408.9 |
| 应付账款 | 626,843,206.48 | 696,431,501.09 | 684,238,022.78 | 791,177,104.83 |
| 预收款项 | 2,180,627.74 | 2,992,124.84 | 255,003.77 | 409,253.54 |
| 合同负债 | 21,646,679.08 | 18,117,222.52 | 22,587,564.8 | 28,346,331.06 |
| 应付职工薪酬 | 32,619,203.3 | 32,836,781.21 | 63,511,442.41 | 75,347,944.75 |
| 应交税费 | 17,692,827.13 | 18,945,145.18 | 16,872,113.95 | 25,863,671.33 |
| 其他应付款合计 | 1,488,856,324.15 | 1,536,949,743.65 | 1,512,668,941.47 | 1,645,656,417.71 |
| 一年内到期的非流动负债 | 110,446,791.18 | 128,560,670.32 | 142,471,616.32 | 32,320,381.18 |
| 其他流动负债 | 618,702.36 | 507,553.19 | 677,626.93 | 881,978.44 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,618,772,615.83 | 2,692,290,914.07 | 2,745,482,706.33 | 2,751,350,825.07 |
| 非流动负债: | | | | |
| 长期借款 | 85,000,000 | 85,000,000 | 559,857,614.54 | 671,257,104.17 |
| 应付债券 | 1,765,533,392.42 | 1,745,431,262.42 | 1,723,193,416.56 | 1,700,958,657.86 |
| 预计负债 | 30,151,967.72 | 76,492,734.6 | 54,031,864 | 64,514,023.3 |
| 递延收益 | 281,656,436.93 | 286,577,312.49 | 289,884,068.48 | 328,701,828.59 |
| 递延所得税负债 | 24,937,092.21 | 24,975,008.99 | 26,852,873.38 | 26,890,790.16 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,187,278,889.28 | 2,218,476,318.5 | 2,653,819,836.96 | 2,792,322,404.08 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,806,051,505.11 | 4,910,767,232.57 | 5,399,302,543.29 | 5,543,673,229.15 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,116,916,739 | 1,116,916,689 | 1,116,916,640 | 1,116,916,552 |
| 其他权益工具 | 511,101,148.51 | 511,101,404.16 | 511,101,659.81 | 511,102,247.8 |
| 资本公积 | 5,409,668,507.43 | 5,420,509,145.82 | 5,395,125,653.4 | 5,369,419,383.54 |
| 其他综合收益 | -137,744.56 | -54,412.97 | - | 0 |
| 盈余公积 | 327,558,677.67 | 327,558,677.67 | 327,558,677.67 | 327,558,677.67 |
| 未分配利润 | 2,344,400,715.39 | 2,158,641,452.6 | 2,270,754,382.56 | 2,216,688,445.11 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,709,508,043.44 | 9,534,672,956.28 | 9,621,457,013.44 | 9,541,685,306.12 |
| 少数股东权益 | -19,834.06 | 15,667.35 | -36,969.88 | 0 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 9,709,488,209.38 | 9,534,688,623.63 | 9,621,420,043.56 | 9,541,685,306.12 |
| 负债和股东权益合计 | 14,515,539,714.49 | 14,445,455,856.2 | 15,020,722,586.85 | 15,085,358,535.27 |
| 公告日期 | 2024-10-26 | 2024-08-29 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |